| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic has been found in Sage X3 12.14.0.50-0. Affected by this vulnerability is an unknown functionality. The manipulation leads to cross site scripting. This vulnerability is listed as CVE-2023-31868. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability was found in Sage X3 12.14.0.50-0 and classified as problematic. This issue affects some unknown processing. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Sage X3 version 12.14.0.50-0 is vulnerable to Cross Site Scripting (XSS). Some parts of the Web application are dynamically built using user's inputs. Yet, those inputs are not verified nor filtered by the application, so they mathed the expected format. Therefore, when HTML/JavaScript code is injected into those fields, this code will be saved by the application and executed by the web browser of the user viewing the web page. Several injection points have been identified on the application. The major one requires the user to be authenticated with a common account, he can then target an Administrator. All others endpoints need the malicious user to be authenticated as an Administrator. Therefore, the impact is diminished.
The weakness was presented 06/22/2023. The advisory is shared at github.com. The identification of this vulnerability is CVE-2023-31868 since 04/29/2023. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2023-36158). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
04/29/2023 🔍06/22/2023 🔍
06/22/2023 🔍
12/29/2025 🔍
Sources
Advisory: github.comStatus: Not defined
CVE: CVE-2023-31868 (🔍)
GCVE (CVE): GCVE-0-2023-31868
GCVE (VulDB): GCVE-100-232133
EUVD: 🔍
Entry
Created: 06/22/2023 14:46Updated: 12/29/2025 05:40
Changes: 06/22/2023 14:46 (37), 07/17/2023 07:15 (11), 12/29/2025 05:40 (16)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.